Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Darunavir/Cobicistat (FDC)
DRUG
2 trials
Sponsors
Janssen Scientific Affairs, LLC
, Instituto Mexicano del Seguro Social
Conditions
Anxiety
HIV
HIV Infections
Insomnia
Pregnancy
Phase 3
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Completed
NCT00855335
Janssen Scientific Affairs, LLC
HIV, HIV Infections, Pregnancy
Start: 2009-04-09
End: 2016-08-11
Updated: 2018-07-06
Phase 4
Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.
Not yet recruiting
NCT06787976
Instituto Mexicano del Seguro Social
Anxiety, HIV, Insomnia
Start: 2025-06-19
End: 2026-01-25
Target: 140
Updated: 2025-06-26
Related Papers
Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study
Infectious Diseases and Therapy
2018-01-15
25 citations